Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis

European Journal of Immunology

Volumn 44, Issue 2, 2014, Pages 339-347

  Benedetti, Giulia ^a   Miossec, Pierre ^a,b  

^a University of Lyon   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Chronicity; Interleukin 17 (IL 17); Rheumatoid arthritis; Th17

Indexed keywords

INTERLEUKIN 17;

APOPTOSIS; ARTICLE; CHRONICITY; EPIGENETICS; FEEDBACK SYSTEM; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIOCYTE;

CHRONICITY; INTERLEUKIN 17 (IL-17); RHEUMATOID ARTHRITIS; TH17;

ANIMALS; ARTHRITIS, RHEUMATOID; HUMANS; INFLAMMATION; INTERLEUKIN-17; TH17 CELLS;

EID: 84893605539     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201344184     Document Type: Article

References (98)

1. Feldmann, M., Brennan, F. M. and Maini, R. N., Rheumatoid arthritis. Cell 1996. 85: 307-310.
2. Zhu, S. and Qian, Y., IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential. Clin. Sci. (Lond) 2012. 122: 487-511.
3. Miossec, P. and Kolls, J. K., Targeting IL-17 and TH17 cells in chronic inflammation. Nat. Rev. Drug Discov. 2012. 11: 763-776.
4. Chabaud, M., Durand, J. M., Buchs, N., Fossiez, F., Page, G., Frappart, L. and Miossec, P., Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 1999. 42: 963-970.
5. Metawi, S. A., Abbas, D., Kamal, M. M. and Ibrahim, M. K., Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA. Clin. Rheumatol. 2011. 30: 1201-1207.
6. Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M. and Weaver, C. T., Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005. 6: 1123-1132.
7. Lubberts, E., Joosten, L. A., van de Loo, F. A., Schwarzenberger, P., Kolls, J. and van den Berg, W. B., Overexpression of IL-17 in the knee joint of collagen type II immunized mice promotes collagen arthritis and aggravates joint destruction. Inflamm. Res. 2002. 51: 102-104.
8. Nakae, S., Nambu, A., Sudo, K. and Iwakura, Y., Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 2003. 171: 6173-6177.
9. Nakae, S., Saijo, S., Horai, R., Sudo, K., Mori, S. and Iwakura, Y., IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc. Natl. Acad. Sci. USA 2003. 100: 5986-5990.
10. Lubberts, E., Schwarzenberger, P., Huang, W., Schurr, J. R., Peschon, J. J., van den Berg, W. B. and Kolls, J. K., Requirement of IL-17 receptor signaling in radiation-resistant cells in the joint for full progression of destructive synovitis. J. Immunol. 2005. 175: 3360-3368.
11. Lubberts, E., Koenders, M. I., Oppers-Walgreen, B., van den Bersselaar, L., Coenen-de Roo, C. J., Joosten, L. A. and van den Berg, W. B., Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum. 2004. 50: 650-659.
12. Jovanovic, D. V., Di Battista, J. A., Martel-Pelletier, J., Jolicoeur, F. C., He, Y., Zhang, M., Mineau, F. et al., IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J. Immunol. 1998. 160: 3513-3521.
13. Cai, X. Y., Gommoll, C. P., Jr., Justice, L., Narula, S. K. and Fine, J. S., Regulation of granulocyte colony-stimulating factor gene expression by interleukin-17. Immunol. Lett. 1998. 62: 51-58.
14. Hamilton, T., Li, X., Novotny, M., Pavicic, P. G., Jr., Datta, S., Zhao, C., Hartupee, J. et al., Cell type- and stimulus-specific mechanisms for post-transcriptional control of neutrophil chemokine gene expression. J. Leukoc. Biol. 2012. 91: 377-383.
15. Hartupee, J., Liu, C., Novotny, M., Li, X. and Hamilton, T., IL-17 enhances chemokine gene expression through mRNA stabilization. J. Immunol. 2007. 179: 4135-4141.
16. Hata, K., Andoh, A., Shimada, M., Fujino, S., Bamba, S., Araki, Y., Okuno, T. et al., IL-17 stimulates inflammatory responses via NF-kappaB and MAP kinase pathways in human colonic myofibroblasts. Am. J. Physiol. Gastrointest. Liver Physiol. 2002. 282: G1035-G1044.
17. Witowski, J., Pawlaczyk, K., Breborowicz, A., Scheuren, A., Kuzlan-Pawlaczyk, M., Wisniewska, J., Polubinska, A. et al., IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J. Immunol. 2000. 165: 5814-5821.
18. Zrioual, S., Ecochard, R., Tournadre, A., Lenief, V., Cazalis, M. A. and Miossec, P., Genome-wide comparison between IL-17A- and IL-17F-induced effects in human rheumatoid arthritis synoviocytes. J. Immunol. 2009. 182: 3112-3120.
19. LeGrand, A., Fermor, B., Fink, C., Pisetsky, D. S., Weinberg, J. B., Vail, T. P. and Guilak, F., Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci. Arthritis Rheum. 2001. 44: 2078-2083.
20. Muhl, H., Bachmann, M. and Pfeilschifter, J., Inducible NO synthase and antibacterial host defence in times of Th17/Th22/T22 immunity. Cell Microbiol. 2011. 13: 340-348.
21. Trajkovic, V., Stosic-Grujicic, S., Samardzic, T., Markovic, M., Miljkovic, D., Ramic, Z. and Mostarica Stojkovic, M., Interleukin-17 stimulates inducible nitric oxide synthase activation in rodent astrocytes. J. Neuroimmunol. 2001. 119: 183-191.
22. Kalinski, P., Regulation of immune responses by prostaglandin E2. J. Immunol. 2012. 188: 21-28.
23. Singh, V. K., Mehrotra, S., Narayan, P., Pandey, C. M. and Agarwal, S. S., Modulation of autoimmune diseases by nitric oxide. Immunol. Res. 2000. 22: 1-19.
24. Barrie, A., Khare, A., Henkel, M., Zhang, Y., Barmada, M. M., Duerr, R. and Ray, A., Prostaglandin E2 and IL-23 plus IL-1beta differentially regulate the Th1/Th17 immune response of human CD161(+) CD4(+) memory T cells. Clin. Transl. Sci. 2011. 4: 268-273.
25. Lemos, H. P., Grespan, R., Vieira, S. M., Cunha, T. M., Verri, W. A., Jr., Fernandes, K. S., Souto, F. O. et al., Prostaglandin mediates IL-23/IL-17-induced neutrophil migration in inflammation by inhibiting IL-12 and IFNgamma production. Proc. Natl. Acad. Sci. USA 2009. 106: 5954-5959.
26. Ganea, D., Kocieda, V., Kong, W. and Yen, J. H., Modulation of dendritic cell function by PGE2 and DHA: a framework for understanding the role of dendritic cells in neuroinflammation. Clin. Lipidol. 2011. 6: 277-291.
27. Paulissen, S. M., van Hamburg, J. P., Davelaar, N., Asmawidjaja, P. S., Hazes, J. M. and Lubberts, E., Synovial fibroblasts directly induce Th17 pathogenicity via the cyclooxygenase/prostaglandin E2 pathway, independent of IL-23. J. Immunol. 2013. 191: 1364-1372.
28. Sheibanie, A. F., Khayrullina, T., Safadi, F. F. and Ganea, D., Prostaglandin E2 exacerbates collagen-induced arthritis in mice through the inflammatory interleukin-23/interleukin-17 axis. Arthritis Rheum. 2007. 56: 2608-2619.
29. Katz, Y., Nadiv, O., Rapoport, M. J. and Loos, M., IL-17 regulates gene expression and protein synthesis of the complement system, C3 and factor B, in skin fibroblasts. Clin. Exp. Immunol. 2000. 120: 22-29.
30. Sugihara, T., Kobori, A., Imaeda, H., Tsujikawa, T., Amagase, K., Takeuchi, K., Fujiyama, Y. et al., The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease. Clin. Exp. Immunol. 2010. 160: 386-393.
31. Lee, J. H., Cho, M. L., Kim, J. I., Moon, Y. M., Oh, H. J., Kim, G. T., Ryu, S. et al., Interleukin 17 (IL-17) increases the expression of Toll-like receptor-2, 4, and 9 by increasing IL-1beta and IL-6 production in autoimmune arthritis. J. Rheumatol. 2009. 36: 684-692.
32. Huang, Q. Q. and Pope, R. M., The role of toll-like receptors in rheumatoid arthritis. Curr. Rheumatol. Rep. 2009. 11: 357-364.
33. Markiewski, M. M. and Lambris, J. D., The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am. J. Pathol. 2007. 171: 715-727.
34. Okroj, M., Heinegard, D., Holmdahl, R. and Blom, A. M., Rheumatoid arthritis and the complement system. Ann. Med. 2007. 39: 517-530.
35. Zhu, S., Pan, W., Song, X., Liu, Y., Shao, X., Tang, Y., Liang, D. et al., The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-alpha. Nat. Med. 2012. 18: 1077-1086.
36. Greer, J. M. and McCombe, P. A., The role of epigenetic mechanisms and processes in autoimmune disorders. Biologics 2012. 6: 307-327.
37. Niimoto, T., Nakasa, T., Ishikawa, M., Okuhara, A., Izumi, B., Deie, M., Suzuki, O. et al., MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients. BMC Musculoskelet. Disord. 2010. 11: 209-220.
38. Du, C., Liu, C., Kang, J., Zhao, G., Ye, Z., Huang, S., Li, Z. et al., MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat. Immunol. 2009. 10: 1252-1259.
39. Hu, R., Huffaker, T. B., Kagele, D. A., Runtsch, M. C., Bake, E., Chaudhuri, A. A., Round, J. L. et al., MicroRNA-155 confers encephalogenic potential to Th17 cells by promoting effector gene expression. J. Immunol. 2013. 190: 5972-5980.
40. Haas, J. D., Nistala, K., Petermann, F., Saran, N., Chennupati, V., Schmitz, S., Korn, T. et al., Expression of miRNAs miR-133b and miR-206 in the Il17a/f locus is co-regulated with IL-17 production in alphabeta and gammadelta T cells. PLoS One 2011. 6: e20171.
41. Karouzakis, E., Gay, R. E., Michel, B. A., Gay, S. and Neidhart, M., DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 2009. 60: 3613-3622.
42. Nakano, K., Boyle, D. L. and Firestein, G. S., Regulation of DNA methylation in rheumatoid arthritis synoviocytes. J. Immunol. 2013. 190: 1297-1303.
43. Richardson, B., Scheinbart, L., Strahler, J., Gross, L., Hanash, S. and Johnson, M., Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 1990. 33: 1665-1673.
44. Akimzhanov, A. M., Yang, X. O. and Dong, C., Chromatin remodeling of interleukin-17 (IL-17)-IL-17F cytokine gene locus during inflammatory helper T cell differentiation. J. Biol. Chem. 2007. 282: 5969-5972.
45. Ma, J., Wang, R., Fang, X., Ding, Y. and Sun, Z., Critical role of TCF-1 in repression of the IL-17 gene. PLoS One 2011. 6: e24768.
46. Hod-Dvorai, R., Jacob, E., Boyko, Y. and Avni, O., The binding activity of Mel-18 at the Il17a promoter is regulated by the integrated signals of the TCR and polarizing cytokines. Eur. J. Immunol. 2011. 41: 2424-2435.
47. Klein, K. and Gay, S., Epigenetic modifications in rheumatoid arthritis, a review. Curr. Opin. Pharmacol. 2013. 13: 420-425.
48. Turner-Brannen, E., Choi, K. Y., Arsenault, R., El-Gabalawy, H., Napper, S. and Mookherjee, N., Inflammatory cytokines IL-32 and IL-17 have common signaling intermediates despite differential dependence on TNF-receptor 1. J. Immunol. 2011. 186: 7127-7135.
49. Ghizzoni, M., Haisma, H. J., Maarsingh, H. and Dekker, F. J., Histone acetyltransferases are crucial regulators in NF-kappaB mediated inflammation. Drug Discov. Today 2011. 16: 504-511.
50. Korb, A., Pavenstadt, H. and Pap, T., Cell death in rheumatoid arthritis. Apoptosis 2009. 14: 447-454.
51. Lee, S. Y., Kwok, S. K., Son, H. J., Ryu, J. G., Kim, E. K., Oh, H. J., Cho, M. L. et al., IL-17-mediated Bcl-2 expression regulates survival of fibroblast-like synoviocytes in rheumatoid arthritis through STAT3 activation. Arthritis Res. Ther. 15: R31.
52. Sonder, S. U., Saret, S., Tang, W., Sturdevant, D. E., Porcella, S. F. and Siebenlist, U., IL-17-induced NF-kappaB activation via CIKS/Act1: physiologic significance and signaling mechanisms. J. Biol. Chem. 2011. 286: 12881-12890.
53. Granet, C. and Miossec, P., Combination of the pro-inflammatory cytokines IL-1, TNF-alpha and IL-17 leads to enhanced expression and additional recruitment of AP-1 family members, Egr-1 and NF-kappaB in osteoblast-like cells. Cytokine 2004. 26: 169-177.
54. Toh, M. L., Gonzales, G., Koenders, M. I., Tournadre, A., Boyle, D., Lubberts, E., Zhou, Y. et al., Role of interleukin 17 in arthritis chronicity through survival of synoviocytes via regulation of synoviolin expression. PLoS One 2010. 5: e13416.
55. Zhang, Q., Wu, J., Cao, Q., Xiao, L., Wang, L., He, D., Ouyang, G. et al., A critical role of Cyr61 in interleukin-17-dependent proliferation of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Rheum. 2009. 60: 3602-3612.
56. Hayashi, S., Miura, Y., Nishiyama, T., Mitani, M., Tateishi, K., Sakai, Y., Hashiramoto, A. et al., Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis. Arthritis Rheum. 2007. 56: 1067-1075.
57. Niederer, F., Ospelt, C., Brentano, F., Hottiger, M. O., Gay, R. E., Gay, S., Detmar, M. et al., SIRT1 overexpression in the rheumatoid arthritis synovium contributes to proinflammatory cytokine production and apoptosis resistance. Ann. Rheum. Dis. 2011. 70: 1866-1873.
58. Beier, U. H., Wang, L., Bhatti, T. R., Liu, Y., Han, R., Ge, G. and Hancock, W. W., Sirtuin-1 targeting promotes Foxp3 +T-regulatory cell function and prolongs allograft survival. Mol. Cell Biol. 2011. 31: 1022-1029.
59. Park, Y. D., Kim, Y. S., Jung, Y. M., Lee, S. I., Lee, Y. M., Bang, J. B. and Kim, E. C., Porphyromonas gingivalis lipopolysaccharide regulates interleukin (IL)-17 and IL-23 expression via SIRT1 modulation in human periodontal ligament cells. Cytokine 2012. 60: 284-293.
60. Fossiez, F., Djossou, O., Chomarat, P., Flores-Romo, L., Ait-Yahia, S., Maat, C., Pin, J. J. et al., T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 1996. 183: 2593-2603.
61. Schwarzenberger, P., Huang, W., Ye, P., Oliver, P., Manuel, M., Zhang, Z., Bagby, G. et al., Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis. J. Immunol. 2000. 164: 4783-4789.
62. Schwarzenberger, P., La Russa, V., Miller, A., Ye, P., Huang, W., Zieske, A., Nelson, S. et al., IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J. Immunol. 1998. 161: 6383-6389.
63. Antonysamy, M. A., Fanslow, W. C., Fu, F., Li, W., Qian, S., Troutt, A. B. and Thomson, A. W., Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors. J. Immunol. 1999. 162: 577-584.
64. Kim, K. W., Cho, M. L., Kim, H. R., Ju, J. H., Park, M. K., Oh, H. J., Kim, J. S. et al., Up-regulation of stromal cell-derived factor 1 (CXCL12) production in rheumatoid synovial fibroblasts through interactions with T lymphocytes: role of interleukin-17 and CD40L-CD40 interaction. Arthritis Rheum. 2007. 56: 1076-1086.
65. Dechanet, J., Merville, P., Durand, I., Banchereau, J. and Miossec, P., The ability of synoviocytes to support terminal differentiation of activated B cells may explain plasma cell accumulation in rheumatoid synovium. J. Clin. Invest. 1995. 95: 456-463.
66. Lindhout, E., van Eijk, M., van Pel, M., Lindeman, J., Dinant, H. J. and de Groot, C., Fibroblast-like synoviocytes from rheumatoid arthritis patients have intrinsic properties of follicular dendritic cells. J. Immunol. 1999. 162: 5949-5956.
67. Hitchon, C. A. and El-Gabalawy, H. S., The synovium in rheumatoid arthritis. Open Rheumatol. J. 2011. 5: 107-114.
68. Zhang, J., Wang, X., Fahmi, H., Wojcik, S., Fikes, J., Yu, Y., Wu, J. et al., Role of TL1A in the pathogenesis of rheumatoid arthritis. J. Immunol. 2009. 183: 5350-5357.
69. Bombardieri, M., Kam, N. W., Brentano, F., Choi, K., Filer, A., Kyburz, D., McInnes, I. B. et al., A BAFF/APRIL-dependent TLR3-stimulated pathway enhances the capacity of rheumatoid synovial fibroblasts to induce AID expression and Ig class-switching in B cells. Ann. Rheum. Dis. 2011. 70: 1857-1865.
70. Doreau, A., Belot, A., Bastid, J., Riche, B., Trescol-Biemont, M. C., Ranchin, B., Fabien, N. et al., Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat. Immunol. 2009. 10: 778-785.
71. Nanki, T., Hayashida, K., El-Gabalawy, H. S., Suson, S., Shi, K., Girschick, H. J., Yavuz, S. et al., Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium. J. Immunol. 2000. 165: 6590-6598.
72. Bhagat, T. D., Zhou, L., Sokol, L., Kessel, R., Caceres, G., Gundabolu, K., Tamari, R. et al., miR-21 mediates hematopoietic suppression in MDS by activating TGF-beta signaling. Blood 2013. 121: 2875-2881.
73. Fang, Y., Yu, S., Ellis, J. S., Sharav, T. and Braley-Mullen, H., Comparison of sensitivity of Th1, Th2, and Th17 cells to Fas-mediated apoptosis. J. Leukoc. Biol. 2010. 87: 1019-1028.
74. Eljaafari, A., Tartelin, M. L., Aissaoui, H., Chevrel, G., Osta, B., Lavocat, F. and Miossec, P., Bone marrow-derived and synovium-derived mesenchymal cells promote Th17 cell expansion and activation through caspase 1 activation: contribution to the chronicity of rheumatoid arthritis. Arthritis Rheum. 64: 2147-2157.
75. Lin, J., Zhou, Z., Huo, R., Xiao, L., Ouyang, G., Wang, L., Sun, Y. et al., Cyr61 induces IL-6 production by fibroblast-like synoviocytes promoting Th17 differentiation in rheumatoid arthritis. J. Immunol. 188: 5776-5784.
76. Ogura, H., Murakami, M., Okuyama, Y., Tsuruoka, M., Kitabayashi, C., Kanamoto, M., Nishihara, M. et al., Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction. Immunity 2008. 29: 628-636.
77. Boniface, K., Bak-Jensen, K. S., Li, Y., Blumenschein, W. M., McGeachy, M. J., McClanahan, T. K., McKenzie, B. S. et al., Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling. J. Exp. Med. 2009. 206: 535-548.
78. Yao, C., Sakata, D., Esaki, Y., Li, Y., Matsuoka, T., Kuroiwa, K., Sugimoto, Y. et al., Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat. Med. 2009. 15: 633-640.
79. Acosta-Rodriguez, E. V., Rivino, L., Geginat, J., Jarrossay, D., Gattorno, M., Lanzavecchia, A., Sallusto, F. et al., Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 2007. 8: 639-646.
80. Reboldi, A., Coisne, C., Baumjohann, D., Benvenuto, F., Bottinelli, D., Lira, S., Uccelli, A. et al., C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat. Immunol. 2009. 10: 514-523.
81. Kellner, H., Targeting interleukin-17 in patients with active rheumatoid arthritis: rationale and clinical potential. Ther. Adv. Musculoskelet. Dis. 2013. 5: 141-152.
82. Nistala, K., Adams, S., Cambrook, H., Ursu, S., Olivito, B., de Jager, W., Evans, J. G. et al., Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc. Natl. Acad. Sci. USA 2010. 107: 14751-14756.
83. Hot, A., Lavocat, F., Lenief, V. and Miossec, P., Simvastatin inhibits the pro-inflammatory and pro-thrombotic effects of IL-17 and TNF-alpha on endothelial cells. Ann. Rheum. Dis. 2013. 72: 754-760.
84. Katz, Y., Nadiv, O. and Beer, Y., Interleukin-17 enhances tumor necrosis factor alpha-induced synthesis of interleukins 1, 6, and 8 in skin and synovial fibroblasts: a possible role as a "fine-tuning cytokine" in inflammation processes. Arthritis Rheum. 2001. 44: 2176-2184.
85. Kehlen, A., Thiele, K., Riemann, D. and Langner, J., Expression, modulation and signalling of IL-17 receptor in fibroblast-like synoviocytes of patients with rheumatoid arthritis. Clin. Exp. Immunol. 2002. 127: 539-546.
86. Shalom-Barak, T., Quach, J. and Lotz, M., Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB. J. Biol. Chem. 1998. 273: 27467-27473.
87. Teunissen, M. B., Koomen, C. W., de Waal Malefyt, R., Wierenga, E. A. and Bos, J. D., Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J. Invest. Dermatol. 1998. 111: 645-649.
88. Yao, Z., Painter, S. L., Fanslow, W. C., Ulrich, D., Macduff, B. M., Spriggs, M. K. and Armitage, R. J., Human IL-17: a novel cytokine derived from T cells. J. Immunol. 1995. 155: 5483-5486.
89. Albanesi, C., Cavani, A. and Girolomoni, G., IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha. J. Immunol. 1999. 162: 494-502.
90. Takaya, H., Andoh, A., Makino, J., Shimada, M., Tasaki, K., Araki, Y., Bamba, S. et al., Interleukin-17 stimulates chemokine (interleukin-8 and monocyte chemoattractant protein-1) secretion in human pancreatic periacinar myofibroblasts. Scand. J. Gastroenterol. 2002. 37: 239-245.
91. Ruddy, M. J., Shen, F., Smith, J. B., Sharma, A. and Gaffen, S. L., Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment. J. Leukoc. Biol. 2004. 76: 135-144.
92. Awane, M., Andres, P. G., Li, D. J. and Reinecker, H. C., NF-kappa B-inducing kinase is a common mediator of IL-17-, TNF-alpha-, and IL-1 beta-induced chemokine promoter activation in intestinal epithelial cells. J. Immunol. 1999. 162: 5337-5344.
93. Miljkovic, D., Cvetkovic, I., Vuckovic, O., Stosic-Grujicic, S., Mostarica Stojkovic, M. and Trajkovic, V., The role of interleukin-17 in inducible nitric oxide synthase-mediated nitric oxide production in endothelial cells. Cell Mol. Life Sci. 2003. 60: 518-525.
94. Faour, W. H., Mancini, A., He, Q. W. and Di Battista, J. A., T-cell-derived interleukin-17 regulates the level and stability of cyclooxygenase-2 (COX-2) mRNA through restricted activation of the p38 mitogen-activated protein kinase cascade: role of distal sequences in the 3'-untranslated region of COX-2 mRNA. J. Biol. Chem. 2003. 278: 26897-26907.
95. Griffin, G. K., Newton, G., Tarrio, M. L., Bu, D. X., Maganto-Garcia, E., Azcutia, V., Alcaide, P. et al., IL-17 and TNF-alpha sustain neutrophil recruitment during inflammation through synergistic effects on endothelial activation. J. Immunol. 2012. 188: 6287-6299.
96. Hot, A., Lenief, V. and Miossec, P., Combination of IL-17 and TNFalpha induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cells. Ann. Rheum. Dis. 2012. 71: 768-776.
97. Martel-Pelletier, J., Mineau, F., Jovanovic, D., Di Battista, J. A. and Pelletier, J. P., Mitogen-activated protein kinase and nuclear factor kappaB together regulate interleukin-17-induced nitric oxide production in human osteoarthritic chondrocytes: possible role of transactivating factor mitogen-activated protein kinase-activated proten kinase (MAPKAPK). Arthritis Rheum. 1999. 42: 2399-2409.
98. Andoh, A., Hata, K., Araki, Y., Fujiyama, Y. and Bamba, T., Interleukin (IL)-4 and IL-17 synergistically stimulate IL-6 secretion in human colonic myofibroblasts. Int. J. Mol. Med. 2002. 10: 631-634.